Back to Search
MEGAN BEAL, PHARM.D.
PHARM.D.
Pharmacist
NPI: 1427467448Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
RP0008664(WV)
Research & Publications (20)
The role of NADPH oxidase 1-derived reactive oxygen species in paraquat-mediated dopaminergic cell death.
PMID 19450058·Antioxid Redox Signal·2009
7-preclinical
Thiamine deficiency induces oxidative stress and exacerbates the plaque pathology in Alzheimer's mouse model.
PMID 18406011·Neurobiol Aging·2009
7-preclinical
Mitochondrial dihydrolipoyl succinyltransferase deficiency accelerates amyloid pathology and memory deficit in a transgenic mouse model of amyloid deposition.
PMID 19596066·Free Radic Biol Med·2009
7-preclinical
Mitochondrial dysfunction in the limelight of Parkinson's disease pathogenesis.
PMID 19059336·Biochim Biophys Acta·2009
6-review
Neuroprotective effects of the triterpenoid, CDDO methyl amide, a potent inducer of Nrf2-mediated transcription.
PMID 19484125·PLoS One·2009
7-preclinical
Mice deficient in dihydrolipoyl succinyl transferase show increased vulnerability to mitochondrial toxins.
PMID 19660549·Neurobiol Dis·2009
4-observational
Dietary supplementation with resveratrol reduces plaque pathology in a transgenic model of Alzheimer's disease.
PMID 19041676·Neurochem Int·2009
7-preclinical
Computed tomographic and magnetic resonance imaging features of canine segmental caudal vena cava aplasia.
PMID 19575698·J Small Anim Pract·2009
4-observational
Mutant LRRK2(R1441G) BAC transgenic mice recapitulate cardinal features of Parkinson's disease.
PMID 19503083·Nat Neurosci·2009
7-preclinical
Reduction of oxidative stress, amyloid deposition, and memory deficit by manganese superoxide dismutase overexpression in a transgenic mouse model of Alzheimer's disease.
PMID 19346295·FASEB J·2009
7-preclinical
Localized Th1-, Th2-, T regulatory cell-, and inflammation-associated hepatic and pulmonary immune responses in Ascaris suum-infected swine are increased by retinoic acid.
PMID 19332534·Infect Immun·2009
7-preclinical
PINK1 defect causes mitochondrial dysfunction, proteasomal deficit and alpha-synuclein aggregation in cell culture models of Parkinson's disease.
PMID 19242547·PLoS One·2009
8-other
Use of a balloon-expandable metallic stent to relieve malignant urethral obstruction in a cat.
PMID 19210243·J Am Vet Med Assoc·2009
5-case
Mitochondria targeted peptides protect against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity.
PMID 19203217·Antioxid Redox Signal·2009
7-preclinical
Combination therapy with coenzyme Q10 and creatine produces additive neuroprotective effects in models of Parkinson's and Huntington's diseases.
PMID 19476553·J Neurochem·2009
7-preclinical
Impaired PGC-1alpha function in muscle in Huntington's disease.
PMID 19460884·Hum Mol Genet·2009
7-preclinical
Inhibition of prolyl hydroxylase protects against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity: model for the potential involvement of the hypoxia-inducible factor pathway in Parkinson disease.
PMID 19679656·J Biol Chem·2009
7-preclinical
A transcriptomic analysis of land-use impacts on the oyster, Crassostrea virginica, in the South Atlantic bight.
PMID 19457208·Mol Ecol·2009
7-preclinical
Multinuclear magnetic resonance spectroscopy for in vivo assessment of mitochondrial dysfunction in Parkinson's disease.
PMID 19076443·Ann N Y Acad Sci·2008
6-review
Mitochondria and oxidative stress in neurodegenerative disorders. Preface.
PMID 19076425·Ann N Y Acad Sci·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 812 GORMAN AVE
ELKINS, WV 26241 - Phone
- (304) 636-6767
Quick Facts
- NPI
- 1427467448
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile